Your browser doesn't support javascript.
loading
Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
Carroll, Andrew J; Shago, Mary; Mikhail, Fady M; Raimondi, Susana C; Hirsch, Betsy A; Loh, Mignon L; Raetz, Elizabeth A; Borowitz, Michael J; Wood, Brent L; Maloney, Kelly W; Mattano, Leonard A; Larsen, Eric C; Gastier-Foster, Julie; Stonerock, Eileen; Ell, Denise; Kahwash, Samir; Devidas, Meenakshi; Harvey, Richard C; Chen, I-Ming L; Willman, Cheryl L; Hunger, Stephen P; Winick, Naomi J; Carroll, William L; Rao, Kathleen W; Heerema, Nyla A.
Afiliação
  • Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: acarroll@uab.edu.
  • Shago M; Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON, Canada.
  • Mikhail FM; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Raimondi SC; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Hirsch BA; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Loh ML; Department of Pediatrics, UCSF Medical Center-Mission Bay, San Francisco, CA, USA.
  • Raetz EA; Department of Pediatrics, New York University Medical Center, New York, NY, USA.
  • Borowitz MJ; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Wood BL; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Maloney KW; Children's Hospital of Colorado, Aurora, CO, USA.
  • Mattano LA; HARP Pharma Consulting, Mystic, CT, USA.
  • Larsen EC; Maine Children's Cancer Program, Scarborough, ME, USA.
  • Gastier-Foster J; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pathology, The Ohio State University, Columbus, OH, USA.
  • Stonerock E; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Ell D; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Kahwash S; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Devidas M; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Harvey RC; University of New Mexico Cancer Center, Albuquerque, NM, USA.
  • Chen IL; University of New Mexico Cancer Center, Albuquerque, NM, USA.
  • Willman CL; University of New Mexico Cancer Center, Albuquerque, NM, USA.
  • Hunger SP; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Winick NJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Carroll WL; Department of Pediatrics, New York University Medical Center, New York, NY, USA.
  • Rao KW; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH, USA.
Cancer Genet ; 238: 62-68, 2019 10.
Article em En | MEDLINE | ID: mdl-31425927
ABSTRACT
Hyperdiploidy with greater than 50 chromosomes is usually associated with favorable prognosis in pediatric acute lymphoblastic leukemia (ALL), whereas hypodiploidy with ≤43 chromosomes is associated with extremely poor prognosis. Sometimes, hypodiploidy is "masked" and patients do not have a karyotypically visible clone with ≤43 chromosomes. Instead, their abnormal karyotypes contain 50-78 or more chromosomes from doubling of previously hypodiploid cells. When the hypodiploid and doubled hyperdiploid clones are both present, patients can be identified by traditional test methods [karyotype, DNA Index (DI), fluorescence in situ hybridization (FISH)], but the incidence of masked hypodiploid cases in which only the doubled clone is visible is unknown. We analyzed 7013 patients with B-ALL enrolled in COG AALL03B1 (2003-2011) for whom chromosome studies were available. Of 115 patients with hypodiploidy (25-39 chromosomes), karyotypes of 40 showed only the hypodiploid clone, 47 showed mosaicism with both hypodiploid and hyperdiploid (doubled) karyotypes, and 28 with masked hypodiploidy showed only a hyperdiploid (doubled) clone. Unique karyotypic signatures were identified, and widespread loss of heterozygosity (LOH) was seen in the microsatellite panel for all patients with masked hypodiploidy. An increased awareness of the unusual karyotypic profile associated with a doubled hypodiploid clone and coordinated use of DI, FISH, and LOH studies when indicated can identify patients with masked hypodiploidy and allow appropriate treatment selection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diploide / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diploide / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article